Literature DB >> 22396231

Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter.

Shiro Itagaki1, Vadivel Ganapathy, Horace T B Ho, Mingyan Zhou, Ellappan Babu, Joanne Wang.   

Abstract

Plasma membrane monoamine transporter (PMAT) is a polyspecific organic cation (OC) transporter that transports a variety of endogenous biogenic amines and xenobiotic cations. Previous radiotracer uptake studies showed that PMAT-mediated OC transport is sensitive to changes in membrane potential and extracellular pH, but the precise role of membrane potential and protons on PMAT-mediated OC transport is unknown. Here, we characterized the electrophysiological properties of PMAT in Xenopus laevis oocytes using a two-microelectrode voltage-clamp approach. PMAT-mediated histamine uptake is associated with inward currents under voltage-clamp conditions, and the currents increased in magnitude as the holding membrane potential became more negative. A similar effect was also observed for another cation, nicotine. Substrate-induced currents were largely independent of Na+ but showed strong dependence on membrane potential and pH of the perfusate. Detailed kinetic analysis of histamine uptake revealed that the energizing effect of membrane potentials on PMAT transport is mainly due to an augmentation of Imax with little effect on K0.5. At most holding membrane potentials, Imax at pH 6.0 is approximately 3- to 4-fold higher than that at pH 7.5, whereas K0.5 is not dependent on pH. Together, these data unequivocally demonstrate PMAT as an electrogenic transporter and establish the physiological inside-negative membrane potential as a driving force for PMAT-mediated OC transport. The important role of membrane potential and pH in modulating the transport activity of PMAT toward OCs suggests that the in vivo activity of PMAT could be regulated by pathophysiological processes that alter physiological pH or membrane potential.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22396231      PMCID: PMC3362792          DOI: 10.1124/dmd.111.042432

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  33 in total

Review 1.  Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants.

Authors:  Tomoe Fujita; Thomas J Urban; Maya K Leabman; Kazumi Fujita; Kathleen M Giacomini
Journal:  J Pharm Sci       Date:  2006-01       Impact factor: 3.534

2.  Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta.

Authors:  R Kekuda; P D Prasad; X Wu; H Wang; Y J Fei; F H Leibach; V Ganapathy
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

3.  cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2.

Authors:  M Okuda; H Saito; Y Urakami; M Takano; K Inui
Journal:  Biochem Biophys Res Commun       Date:  1996-07-16       Impact factor: 3.575

4.  Interaction of organic cations with a newly identified plasma membrane monoamine transporter.

Authors:  Karen Engel; Joanne Wang
Journal:  Mol Pharmacol       Date:  2005-08-11       Impact factor: 4.436

5.  Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells.

Authors:  D Gründemann; J Babin-Ebell; F Martel; N Ording; A Schmidt; E Schömig
Journal:  J Biol Chem       Date:  1997-04-18       Impact factor: 5.157

6.  Cloning and characterization of two human polyspecific organic cation transporters.

Authors:  V Gorboulev; J C Ulzheimer; A Akhoundova; I Ulzheimer-Teuber; U Karbach; S Quester; C Baumann; F Lang; A E Busch; H Koepsell
Journal:  DNA Cell Biol       Date:  1997-07       Impact factor: 3.311

7.  The amino acid transport system y+L induced in Xenopus laevis oocytes by human choriocarcinoma cell (JAR) mRNA is functionally related to the heavy chain of the 4F2 cell surface antigen.

Authors:  Y J Fei; P D Prasad; F H Leibach; V Ganapathy
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

8.  Identification and characterization of a novel monoamine transporter in the human brain.

Authors:  Karen Engel; Mingyan Zhou; Joanne Wang
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

9.  Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain.

Authors:  X Wu; R Kekuda; W Huang; Y J Fei; F H Leibach; J Chen; S J Conway; V Ganapathy
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

10.  Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.

Authors:  Y Urakami; M Okuda; S Masuda; H Saito; K I Inui
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

View more
  13 in total

Review 1.  Choroid Plexus and Drug Removal Mechanisms.

Authors:  Austin Sun; Joanne Wang
Journal:  AAPS J       Date:  2021-05-03       Impact factor: 4.009

Review 2.  Equilibrative nucleoside transporters-A review.

Authors:  Rebba C Boswell-Casteel; Franklin A Hays
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2016-10-19       Impact factor: 1.381

3.  Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours.

Authors:  T Lee Gilman; Christina M George; Melissa Vitela; Myrna Herrera-Rosales; Mohamed S Basiouny; Wouter Koek; Lynette C Daws
Journal:  Eur J Neurosci       Date:  2018-05-24       Impact factor: 3.386

Review 4.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

5.  Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene.

Authors:  Haichuan Duan; Joanne Wang
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

6.  Coexistence of passive and proton antiporter-mediated processes in nicotine transport at the mouse blood-brain barrier.

Authors:  Salvatore Cisternino; Hélène Chapy; Pascal André; Maria Smirnova; Marcel Debray; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2012-12-05       Impact factor: 4.009

Review 7.  The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.

Authors:  J Wang
Journal:  Clin Pharmacol Ther       Date:  2016-09-19       Impact factor: 6.875

8.  Residue Ile89 in human plasma membrane monoamine transporter influences its organic cation transport activity and sensitivity to inhibition by dilazep.

Authors:  Horace T B Ho; Li Xia; Joanne Wang
Journal:  Biochem Pharmacol       Date:  2012-05-04       Impact factor: 5.858

Review 9.  Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics.

Authors:  David J Wagner; Tao Hu; Joanne Wang
Journal:  Pharmacol Res       Date:  2016-06-16       Impact factor: 7.658

10.  Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier.

Authors:  Horace T B Ho; Amber Dahlin; Joanne Wang
Journal:  Front Pharmacol       Date:  2012-08-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.